Company intelligence / Profile preview

Diathegene

Evry, Île-de-France, France

Ownership: Private
Development stage: Other

Overview

Diathégène was a French biotechnology company specialized in the development of molecular diagnostic tests for infectious diseases and oncology. Founded in 1999 and based in the Genopole biocluster in Evry, the company focused on identifying genetic markers and developing high-throughput screening tools. Diathégène's core expertise lay in molecular biology and the creation of diagnostic kits for clinical use. The company was acquired by the genomics firm Genset in 2001 to strengthen its diagnostic capabilities. Following subsequent acquisitions, its assets were eventually integrated into Serono and later Merck KGaA.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Molecular diagnostics
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Diathegene.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diathegene.

Explore the full profile